Research Examines Link Between Vitiligo and Systemic Sclerosis
Drug Topics
NOVEMBER 21, 2022
Israeli researchers find more than fivefold risk of developing systemic sclerosis among people with vitiligo.
Sat.Nov 19, 2022 - Fri.Nov 25, 2022
528 
The next era of Greater Boston’s biotech boom
PharmaVoice
NOVEMBER 22, 2022
How Boston became the biotech capital of the U.S., and is now preparing for the next era of life sciences growth.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
The 340B program is interfering with the U.S. biosimilars market and impacting patient costs
PhRMA
NOVEMBER 21, 2022
Research has shown that 340B hospitals are more likely to prescribe more expensive medicines and significantly mark up the price of medicines. For example, 340B hospitals received nearly five times what they paid, on average, to acquire oncology medicines through 340B. These practices have implications for what patients pay out of pocket — and new research adds to the evidence.
Dental Health Plays Vital Role in Cardiovascular Well-Being
Pharmacy Times
NOVEMBER 21, 2022
Research also focuses on connection between oral hygiene and other chronic diseases, neurological disorders, pulmonary infections.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Best of COVID-19 Coverage in 2022
Drug Topics
NOVEMBER 24, 2022
Take a look back at our most popular COVID-19 coverage for 2022.
How bacteria-enabled technology for wounds could also help cancer patients
PharmaVoice
NOVEMBER 22, 2022
Evelina Vågesjö, co-founder and CEO of the immunotherapy company Ilya Pharma, is working on a new modality to speed wound healing.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
AI will continue to attract investment in near future in the healthcare industry
Pharmaceutical Technology
NOVEMBER 25, 2022
Artificial intelligence (AI) was seen as one of the top current investment priorities and was thought to continue to attract investment in the healthcare sector in the upcoming two years, according to GlobalData's latest report ‘Digital Transformation and Emerging Technology in the Healthcare Industry - 2022 Edition’. In this survey-based report tracker, digital media was prioritised as a top current investment target, with 53% of surveyed respondents confirming that their companies are currentl
Best of Diabetes Coverage in 2022
Drug Topics
NOVEMBER 23, 2022
Take a look back at our most popular diabetes coverage for 2022.
In cancers with very low survival rates, Sellas aims higher
PharmaVoice
NOVEMBER 21, 2022
The company hopes its drugs can “take over where other available treatments fail” in multiple types of cancer.
Putting Delaware patients first: Protecting Patient Assistance Programs
PhRMA
NOVEMBER 22, 2022
Patients with chronic health conditions in Delaware are seeing a new wave of relief thanks to Governor John Carney, members of the Delaware legislature and more than 40 patient groups. The recently passed SB267 will make it easier for vulnerable patients to be able to afford their brand medications.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Opinion: A tripledemic hurricane is making landfall. We need masks, not just tent hospitals
STAT
NOVEMBER 22, 2022
A viral hurricane is making landfall on health care systems battered by three pandemic years. With the official start of winter still weeks away, pediatric hospitals are facing crushing caseloads of children sick with RSV and other viral illnesses. Schools that promised a “return to normal” now report widespread absences and even closures from RSV and flu in many parts of the country , contributing to parents missing work in record numbers.
Juvenile Idiopathic Inflammatory Myopathies Following COVID-19 Infection
Drug Topics
NOVEMBER 23, 2022
In a recent study, racial minorities of an older age with non-classic cutaneous manifestations were more often to present with juvenile idiopathic inflammatory myopathies after COVID-19 infection.
Why the biopharma ‘IPO playbook’ changed in 2022
PharmaVoice
NOVEMBER 21, 2022
Biopharma IPOs have puttered in 2022, particularly compared to the record-breaking previous year, but they might be set to rebound.
Workplace Stress Was Highest Among Younger Employees During COVID-19 Pandemic
Pharmacy Times
NOVEMBER 23, 2022
Study finds early career workers were more likely to disengage during the pandemic, such as by showing a lack of interest or becoming cynical about work.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Real-world data show updated Covid-19 boosters increase protection against infection
STAT
NOVEMBER 22, 2022
The updated Covid-19 boosters increase people’s protection against symptomatic infection from the coronavirus, according to some of the first estimates of how the shot is performing in the real world and in people, not just in lab experiments. What’s more, that protection was even stronger when people waited a longer period of time since their last dose of the original shot.
Antibiotic Exposure Linked to Increased Risk of Type 2 Diabetes Later in Life
Drug Topics
NOVEMBER 24, 2022
European research examines antibiotic exposure and its potential impact on future type 2 diabetes risk.
First-in-human gene therapy trial for major cardiac syndrome
European Pharmaceutical Review
NOVEMBER 21, 2022
The first-in-human gene therapy trial for heart failure patients with preserved ejection fraction (HFpEF) has been approved by the US Food & Drug Administration (FDA). SRD-001, the adenovirus associated virus (AAV)-based gene therapy is delivered to cardiac ventricular muscle cells via an intracoronary infusion system (produced by Sardocor, a clinical-stage gene therapy subsidiary of Medera), to increase the protein expression and functional activity of sarcoplasmic reticulum calcium ATPase
Multiple SARS-CoV-2 Infections May Elevate Risk of Organ Failure, Death
Pharmacy Times
NOVEMBER 21, 2022
Individuals with COVID-19 reinfections were twice as likely to die and three times more likely to be hospitalized than those who did not have COVID-19 multiple times.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT+: FDA approves a gene therapy for the inherited bleeding disorder hemophilia B
STAT
NOVEMBER 22, 2022
The Food and Drug Administration on Tuesday approved the first gene therapy to treat people with hemophilia B, an inherited bleeding disorder. The one-time treatment, called Hemgenix, was developed by the Dutch biotech company UniQure and will be marketed by CSL Behring, an Australian pharmaceutical company.
Best of Health Systems Coverage in 2022
Drug Topics
NOVEMBER 25, 2022
Take a look back at our most popular health system coverage for 2022.
Woman of the Week: Myriad Genetics’ Nicole Lambert
PharmaVoice
NOVEMBER 23, 2022
Empowered by her own cancer journey, Nicole Lambert is using her platform as chief operating officer of the genetic testing powerhouse to change the trajectory of care for millions of women.
Kidney Damage From Diabetes Worsens Over Time
Pharmacy Times
NOVEMBER 25, 2022
Pharmacists play a significant role in the comprehensive management of this condition through education, intervention, and monitoring.
Experimental flu vaccine, developed using mRNA, seen as potential game changer
STAT
NOVEMBER 24, 2022
An experimental influenza vaccine developed using messenger RNA technology appears capable of inducing what should be a protective immune response against all known subtypes of flu, at least in animals. If the work is translated into humans it could turn out to be a version of a long-sought universal vaccine. This would not be a vaccine that would block all flu infections, nor would it replace the need for an annual flu shot.
Flash Glucose Monitoring May Prompt Lifestyle Changes in Prediabetes
Drug Topics
NOVEMBER 21, 2022
New research indicates that glucose monitoring could lead to lifestyle changes during prediabetes.
Executive changes at Teva, Eversana could spell commercial growth in the new year
PharmaVoice
NOVEMBER 23, 2022
With their latest personnel moves, these life sciences companies are preparing for major business shifts.
Locking Prescription Vials Helps Keep Medicine Safe in Medication-assisted Treatment Programs
Pharmacy Times
NOVEMBER 23, 2022
For patients with opioid use disorder, medication-assisted treatment programs are a clinically effective approach.
House lawmakers press Biden admin to change latest surprise billing rule
Fierce Healthcare
NOVEMBER 21, 2022
House lawmakers press Biden admin to change latest surprise billing rule. rking. Mon, 11/21/2022 - 17:18.
News Roundup: November 21 to November 25
Drug Topics
NOVEMBER 25, 2022
Your weekly roundup of the latest news from Drug Topics®.
Can a formal needs assessment simplify Speaker Bureau compliance?
PharmaVoice
NOVEMBER 21, 2022
In the biopharmaceutical industry, phases of innovation and change are often driven by regulatory action.
New Tool Developed to Track How Breast Cancer Grows
Pharmacy Times
NOVEMBER 21, 2022
New system combines computational and experimental techniques to map evolutionary cancer lineages in their natural habitat of human tissue.
FDA approves first gene therapy for Haemophilia B
European Pharmaceutical Review
NOVEMBER 23, 2022
The US Food and Drug Administration (FDA) has approved Hemgenix (etranacogene dezaparvovec), the first gene therapy for adults with Haemophilia B (congenital Factor IX deficiency) who currently use Factor IX prophylaxis therapy, or have current or historical life-threatening haemorrhage, or have repeated, serious spontaneous bleeding episodes. Standard treatment for the condition involves replacing the missing or deficient clotting factor to improve the body’s ability to stop bleeding and promot
Inflation Reduction Act and Its Impact on Pharmaceutical Pricing and Investment Decisions
Drug Topics
NOVEMBER 23, 2022
The reference to “maximum fair price” in the act bodes poorly for manufacturers and suggests more of a take-it-or-leave-it situation rather than a negotiation where clinical evidence would be the prevailing factor in determining price.
Google rolls out search features that aim to make it easier to sign up for Medicaid, Medicare
Fierce Healthcare
NOVEMBER 23, 2022
Google rolls out search features that aim to make it easier to sign up for Medicaid, Medicare. pminemyer. Wed, 11/23/2022 - 11:12.
Let's personalize your content